Smith Group Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-318,638
Closed -$22M 320
2020
Q2
$22M Sell
318,638
-46,231
-13% -$3.29M 1.21% 24
2020
Q1
$23M Sell
364,869
-32,136
-8% -$2.32M 1.25% 24
2019
Q4
$30.9M Buy
+397,005
New +$31M 1.29% 21
2017
Q4
Sell
-733,080
Closed -$26.7M 447
2017
Q3
$26.7M Sell
733,080
-176,400
-19% -$6.73M 0.89% 36
2017
Q2
$35.8M Sell
909,480
-326,700
-26% -$11.9M 1.1% 31
2017
Q1
$38.8M Sell
1,236,180
-101,400
-8% -$3.17M 1.12% 30
2016
Q4
$41.8M Sell
1,337,580
-18,480
-1% -$599K 1.22% 26
2016
Q3
$54.5M Sell
1,356,060
-11,910
-0.9% -$449K 1.6% 17
2016
Q2
$45.5M Sell
1,367,970
-213,240
-13% -$7.3M 1.36% 22
2016
Q1
$46.5M Sell
1,581,210
-250,740
-14% -$6.92M 1.39% 25
2015
Q4
$48.2M Buy
1,831,950
+346,110
+23% +$8.99M 1.43% 18
2015
Q3
$35.2M Sell
1,485,840
-129,600
-8% -$3.13M 1.34% 16
2015
Q2
$38.3M Buy
1,615,440
+900
+0.1% +$20.3K 1.29% 19
2015
Q1
$38.3M Hold
1,614,540
1.28% 19
2014
Q4
$34.3M Sell
1,614,540
-560,220
-26% -$11.3M 1.2% 20
2014
Q3
$37M Buy
2,174,760
+12,960
+0.6% +$205K 1.37% 12
2014
Q2
$30.9M Buy
+2,161,800
New +$29.3M 1.14% 17

Other funds holding EW

Smith Group Asset Management's EW Position: Q3 2020 in Review

Smith Group Asset Management sold out of Edwards Lifesciences (EW) in Q3 2020, closing a stake of 318,638 shares — an estimated $22M sold.

Smith Group Asset Management first reported a position in EW in Q2 2014 and held it in 17 quarters. The position peaked at $54.5M in Q3 2016. 1,084 funds tracked by Wall St. Rank hold EW as of Q3 2020.

  • Smith Group Asset Management reported no remaining Edwards Lifesciences position as of Q3 2020 after selling out during the quarter.
  • Smith Group Asset Management sold 318,638 Edwards Lifesciences shares in Q3 2020, an estimated $22M.
  • Smith Group Asset Management first reported a position in Edwards Lifesciences in Q2 2014 and held it in 17 quarters.
  • Smith Group Asset Management's Edwards Lifesciences position peaked at $54.5M in Q3 2016.
  • 1,084 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2020.

Based on Smith Group Asset Management's 13F filing for Q3 2020, filed 4 Nov 2020.